OneSource Specialty (ONESOURCE) | Financial Analysis & Statements
OneSource Specialty Pharma Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
3.3B
Gross Profit
2.3B
71.61%
Operating Income
206.8M
6.32%
Net Income
-1.9M
-0.06%
EPS (Diluted)
₹-0.02
Balance Sheet Metrics
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
OneSource Specialty Income Statement From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 14.4B | 1.7B | 387.1M |
| Cost of Goods Sold | 4.4B | 705.1M | 204.1M |
| Gross Profit | 10.1B | 1.0B | 183.0M |
| Gross Margin % | 69.9% | 59.0% | 47.3% |
| Operating Expenses | |||
| Research & Development | 20.5M | 0 | - |
| Selling, General & Administrative | 1.2B | 228.7M | 327.6M |
| Other Operating Expenses | 1.9B | 756.8M | 583.9M |
| Total Operating Expenses | 3.1B | 985.4M | 911.5M |
| Operating Income | 1.9B | -1.6B | -2.2B |
| Operating Margin % | 13.2% | -91.0% | -557.6% |
| Non-Operating Items | |||
| Interest Income | 158.1M | 19.2M | 15.8M |
| Interest Expense | 1.5B | 854.0M | 401.1M |
| Other Non-Operating Income | - | - | - |
| Pre-tax Income | -670.7M | -3.7B | -4.2B |
| Income Tax | -497.8M | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% |
| Net Income | -179.7M | -3.9B | -8.0B |
| Net Margin % | -1.2% | -227.5% | -2,066.0% |
| Key Metrics | |||
| EBITDA | 4.7B | -638.5M | -1.2B |
| EPS (Basic) | ₹-1.63 | ₹-34.18 | ₹-192.51 |
| EPS (Diluted) | ₹-1.63 | ₹-34.18 | ₹-192.51 |
| Basic Shares Outstanding | 110400306 | 114436021 | 41546999 |
| Diluted Shares Outstanding | 110400306 | 114436021 | 41546999 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
OneSource Specialty Balance Sheet From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Current Assets | |||
| Cash & Equivalents | 1.6B | 64.7M | 49.7M |
| Short-term Investments | 540.6M | 157.9M | 45.0M |
| Accounts Receivable | 4.2B | 552.4M | 38.2M |
| Inventory | 1.6B | 112.3M | 1.3B |
| Other Current Assets | 1.7B | - | - |
| Total Current Assets | 10.9B | 1.8B | 2.3B |
| Non-Current Assets | |||
| Property, Plant & Equipment | 9.0B | 0 | 0 |
| Goodwill | 92.1B | 3.3B | 3.4B |
| Intangible Assets | 15.5B | 3.3B | 3.4B |
| Long-term Investments | - | - | - |
| Other Non-Current Assets | 470.9M | - | - |
| Total Non-Current Assets | 64.6B | 11.3B | 17.8B |
| Total Assets | 75.5B | 13.1B | 20.1B |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | 1.8B | 810.2M | 948.2M |
| Short-term Debt | 5.6B | 2.9B | 5.1B |
| Current Portion of Long-term Debt | - | - | - |
| Other Current Liabilities | 2.5B | 59.6M | 59.6M |
| Total Current Liabilities | 11.1B | 6.3B | 8.7B |
| Non-Current Liabilities | |||
| Long-term Debt | 3.8B | 2.8B | 3.6B |
| Deferred Tax Liabilities | 1.6B | 0 | - |
| Other Non-Current Liabilities | 11.9M | - | - |
| Total Non-Current Liabilities | 5.6B | 2.8B | 3.6B |
| Total Liabilities | 16.7B | 9.1B | 12.2B |
| Equity | |||
| Common Stock | 114.4M | 40.1M | 40.1M |
| Retained Earnings | -18.4B | -18.2B | -14.3B |
| Treasury Stock | - | - | - |
| Other Equity | - | - | - |
| Total Shareholders Equity | 58.8B | 4.0B | 7.9B |
| Key Metrics | |||
| Total Debt | 9.4B | 5.7B | 8.6B |
| Working Capital | -273.8M | -4.5B | -6.4B |
Balance Sheet Composition
OneSource Specialty Cash Flow Statement From 2023 to 2025
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -677.6M | -3.9B | -8.0B |
| Depreciation & Amortization | - | - | - |
| Stock-Based Compensation | 43.1M | 19.6M | 59.6M |
| Working Capital Changes | -3.0B | 119.6M | 66.0M |
| Operating Cash Flow | -2.2B | -3.3B | -6.7B |
| Investing Activities | |||
| Capital Expenditures | - | - | - |
| Acquisitions | 0 | -37.9M | 0 |
| Investment Purchases | 0 | -394.2M | -268.7M |
| Investment Sales | - | 610.2M | - |
| Investing Cash Flow | -861.6M | 6.3B | -268.7M |
| Financing Activities | |||
| Share Repurchases | - | - | - |
| Dividends Paid | - | - | - |
| Debt Issuance | 2.5B | 6.5B | 528.5M |
| Debt Repayment | -6.3B | -8.0B | -4.9B |
| Financing Cash Flow | 5.9B | -2.8B | 2.3B |
| Free Cash Flow | -2.0B | -1.7B | -2.1B |
| Net Change in Cash | 2.9B | 243.1M | -4.7B |
Cash Flow Trend
OneSource Specialty Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
936.63
Forward P/E
42.24
Price to Book
3.11
Price to Sales
13.01
PEG Ratio
42.24
Profitability Ratios
Profit Margin
1.42%
Operating Margin
-18.02%
Return on Equity
-0.31%
Return on Assets
-0.24%
Financial Health
Current Ratio
1.02
Debt to Equity
21.93
Per Share Data
EPS (TTM)
₹1.72
Book Value per Share
₹518.08
Revenue per Share
₹124.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ONESOURCE | 202.8B | 936.63 | 3.11 | -0.31% | 1.42% | 21.93 |
| Biocon | 566.5B | 71.84 | 1.68 | 3.66% | 3.59% | 50.02 |
| Concord Biotech | 106.3B | 34.14 | 5.86 | 20.50% | 26.97% | 0.09 |
| Blue Jet Healthcare | 70.0B | 23.87 | 5.56 | 26.93% | 27.88% | 1.64 |
| Supriya Lifescience | 51.7B | 27.94 | 4.78 | 18.86% | 25.19% | 0.48 |
| Zota Health Care | 39.4B | -62.53 | 12.61 | -24.83% | -15.37% | 56.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.





